Acquisition of a 400MHz Solution NMR System with an Autosampler
Acquisition of a 400MHz Solution NMR System with an Autosampler
批准号:
7790824
负责人:
WEI LI
金额:
$25.29万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-25 至 2011-08-24
关键词:
17 year oldAgingBiomedical ResearchCell NucleusDrug Delivery SystemsFundingHealth SciencesLicensingMeasurementMolecularPerformancePharmaceutical ChemistryProcessResearchResearch Project GrantsResearch TrainingSamplingSolutionsSystemTennesseeTimeUnited States National Institutes of HealthUniversitiesWalkingcommercializationdrug candidatedrug discoverygraduate studentinstrumentresearch studytwo-dimensional
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The University of Tennessee Health Science Center is requesting funds to purchase a new 400 MHz NMR spectrometer that will replace our 17-year old Bruker ARX-300 MHz NMR. Together with a well equipped 500 MHz instrument for advanced NMR experiments, this instrument will be managed within the campus's Shared NMR Facility. This instrument will support many on-going, NIH funded research projects that mainly focus on small molecular drug discovery and drug delivery. The 300 MHz NMR has been used for routine NMR studies in a walk-up mode. The requested new, simple two-channel solution 400 MHz NMR is needed to replace the aging and technically limited 300 NMR. It will be equipped with a basic sample changer and one broadband probe that automatically tune to nuclei usually encountered in medicinal chemistry (1H, 19F, 13C, 31P and 15N). It offers significantly greater sensitivity, higher throughput, and substantially better performance compared with the old 300 NMR that it replaces. It will also provide capability for automated, routine two dimensional NMR measurements for medicinal chemists, freeing up valuable instrument time on the 500 MHz NMR which is needed for many advanced experiments for on-going and expanded NIH supported projects. The actively shielded magnet has greatly reduced stray field which will allow us to make better use of valuable lab space. Several drug candidates discovered through NIH funded research on this campus have been licensed and are in the commercialization process. The acquisition of the new 400 MHz will enhance NIH funded biomedical research and the training of graduate students substantially. The University of Tennessee Health Science Center has strong commitment to support biomedical research, as evidenced by the fact that both current NMR instruments were purchased and well maintained with funds from the university.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting brain and bone metastases in metastatic breast cancer for improved patient survival
-
批准号:10564604
-
项目类别:
-
资助金额:$61.49万
-
财政年份:2023
-
负责人:WEI LI
-
依托单位:
Developing a selective TRPC3 ion channel inhibitor for epilepsy treatment
-
批准号:10819354
-
项目类别:
-
资助金额:$42.99万
-
财政年份:2023
-
负责人:WEI LI
-
依托单位:
Dual inhibition of MDM2 and XIAP as a therapeutic strategy in cancer
-
批准号:10224705
-
项目类别:
-
资助金额:$54.15万
-
财政年份:2020
-
负责人:WEI LI
-
依托单位:
Dual inhibition of MDM2 and XIAP as a therapeutic strategy in cancer
-
批准号:10652443
-
项目类别:
-
资助金额:$53.07万
-
财政年份:2020
-
负责人:WEI LI
-
依托单位:
Selective Targeting Survivin for Cancer Therapy
-
批准号:9922228
-
项目类别:
-
资助金额:$38.01万
-
财政年份:2016
-
负责人:WEI LI
-
依托单位:
Selective Targeting Survivin for Cancer Therapy
-
批准号:9254523
-
项目类别:
-
资助金额:$38.01万
-
财政年份:2016
-
负责人:WEI LI
-
依托单位:
Discovery of tissue-selective, nonhypercalcemic VDR modulators for RA treatment
-
批准号:8511162
-
项目类别:
-
资助金额:$15.94万
-
财政年份:2013
-
负责人:WEI LI
-
依托单位:
Acquisition of a Q-TOF Mass Spectrometer
-
批准号:8246986
-
项目类别:
-
资助金额:$32.5万
-
财政年份:2012
-
负责人:WEI LI
-
依托单位:
Discovery of Novel Thiazole Analogs for Treating Malignant Melanoma
-
批准号:8403695
-
项目类别:
-
资助金额:$28.87万
-
财政年份:2011
-
负责人:WEI LI
-
依托单位:
Discovery of Novel Thiazole Analogs for Treating Malignant Melanoma
-
批准号:8589375
-
项目类别:
-
资助金额:$29.79万
-
财政年份:2011
-
负责人:WEI LI
-
依托单位:
Targeting the colchicine binding site in tubulin for cancer therapy
-
批准号:10298280
-
项目类别:
-
资助金额:$40.33万
-
财政年份:2011
-
负责人:WEI LI
-
依托单位:
Discovery of Novel Thiazole Analogs for Treating Malignant Melanoma
-
批准号:8041517
-
项目类别:
-
资助金额:$30.71万
-
财政年份:2011
-
负责人:WEI LI
-
依托单位:
Targeting the colchicine binding site in tubulin for cancer therapy
-
批准号:10680394
-
项目类别:
-
资助金额:$38.98万
-
财政年份:2011
-
负责人:WEI LI
-
依托单位:
Targeting the colchicine binding site in tubulin for cancer therapy
-
批准号:10458768
-
项目类别:
-
资助金额:$38.2万
-
财政年份:2011
-
负责人:WEI LI
-
依托单位:
Discovery of Novel Thiazole Analogs for Treating Malignant Melanoma
-
批准号:8787452
-
项目类别:
-
资助金额:$30.71万
-
财政年份:2011
-
负责人:WEI LI
-
依托单位:
Targeting the colchicine site in tubulin for advanced melanoma
-
批准号:9033412
-
项目类别:
-
资助金额:$39.14万
-
财政年份:2011
-
负责人:WEI LI
-
依托单位:
Discovery of Novel Thiazole Analogs for Treating Malignant Melanoma
-
批准号:8207242
-
项目类别:
-
资助金额:$30.71万
-
财政年份:2011
-
负责人:WEI LI
-
依托单位:
Discovery of Novel Cytotoxic Agents for Advanced Melanoma
-
批准号:7458255
-
项目类别:
-
资助金额:$21.9万
-
财政年份:2008
-
负责人:WEI LI
-
依托单位:
Novel rod and blue cone signaling pathways in the retina
-
批准号:7212253
-
项目类别:
-
资助金额:$1.89万
-
财政年份:2006
-
负责人:WEI LI
-
依托单位:
Novel rod and blue cone signaling pathways in the retina
-
批准号:7052267
-
项目类别:
-
资助金额:$4.88万
-
财政年份:2006
-
负责人:WEI LI
-
依托单位:
海外基金